Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Conditions: Haemodialysis; Chronic Kidney Disease Requiring Chronic Dialysis; Cardiovascular Disease; Cardiovascular Risk Factor; Hyperoxalemia Interventions: Drug: Lumasiran Sponsors: Charite University, Berlin, Germany; Alnylam Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials